Frazier Management LLC Regenxbio Inc. Transaction History

Frazier Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$24.62 - $34.31 $5.81 Million - $8.09 Million	-235,809 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$29.09 - $45.68 $3.38 Million - $5.31 Million	-116,145 Reduced 33.0%	235,809 $9.89 Million
Q1 2021 May 12, 2021	BUY	$33.61 - $49.95 $336,100 - $499,500	10,000 Added 2.92%	351,954 $12 Million
Q4 2020 Feb 11, 2021	BUY	$26.52 - $49.35 $4.45 Million - $8.28 Million	167,754 Added 96.3%	341,954 $15.5 Million
Q3 2020 Nov 12, 2020	BUY	$27.01 - $40.26 $4.71 Million - $7.01 Million	174,200 New	174,200 $4.79 Million

193

43.5M

58.9K

58.4K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $404M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.